The Company
We are a pharmaceutical company operating in the healthcare sector in Greece and Cyprus since 2013.
We are a pharmaceutical company operating in the healthcare sector in Greece and Cyprus since 2013.
Having strong international partnerships, we are actively engaged in the pharmaceutical market with well-established medicinal products, medical devices and dietary supplements.
We are ISO 9001: 2015 certified for handling our product import, storage, trading and distribution.
Our vision is to consistently help to improving the real-time clinical practice for Health Care Professionals. We constantly strive, through innovative products, to help improving the quality of provided healthcare services.
Mindset
People are always at the center
Reliability
We offer the highest ISO standards for quality and safety
Consistency
We support the clinical practice applied by the Greek HCPs
Innovation
We invest in innovation with technologically advanced products
HISTORY
2013
Stilvi Pharmaceuticals S.A. was established in 2013 by experienced executives in the pharmaceutical sector along the lines of their values and against the background of long and successful careers in the pharmaceutical industry.
Within a short period of time, Stilvi Pharmaceuticals S.A. gained recognition from the medical community, equivalent to the recognition already cherished by its founders.
2013 – TODAY
From 2013 to this day, Stilvi Pharmaceuticals S.A. offers specialized products for the treatment of urinary diseases for patients suffering from:
Non-muscle invasive bladder cancer
Urinary infections
Reduced fertilizing capacity
2013 – TODAY
From 2013 to this day, Stilvi Pharmaceuticals S.A. offers specialized products for the treatment of urinary diseases for patients suffering from:
Non-muscle invasive bladder cancer
Urinary infections
Reduced fertilizing capacity
2017
Stilvi Pharmaceuticals S.A. staffed its R&D division, in order to develop its own products.
2018
In 2018, the Company develops its own series of cosmetic products, using unique Greek raw materials, such as Chios Mastic. The series, with trade name IONIAN MYSTERY, is exported to Japan.
2018
In 2018, the Company develops its own series of cosmetic products, using unique Greek raw materials, such as Chios Mastic. The series, with trade name IONIAN MYSTERY, is exported to Japan.
Human Resources
Our ‘People’ are our greatest and most valuable
asset.
Our ‘People’ are our greatest and most valuable asset.
We offer a safe and stable work environment, as our aim is to ensure long-term collaborations.
We attach high importance to training our people, aiming to ensure an organization where people can progress and collaborate in harmony.
All our employees attend the continuing training and development programme introduced by our Company in 2018, in order to:
- Obtain thorough scientific training
- Improve their competences
- Enhance their skills
- Achieve balance in their professional life
- Progress
Our people are characterised by their professionalism, ethos, team spirit, and integrity, characteristics that reflect the rules and policies developed and implemented by the management of the organization.
MANAGEMENT TEAM
Tasos Gkousis
Serving the pharmaceutical industry for more than 25 years, Tasos Gkousis has held marketing, sales and management positions in leading pharmaceutical companies, both in Greece and abroad.
Being primarily engaged in the development and implementation of a trading strategy for the positioning of new medicines in the market, as well as planning the management of a multinational company branch, he has a successful career background in various operational and manager roles. Important milestones in his career include placing worldwide first-in-class preparations in the Greek and Cypriot market, creating and developing new branches in Greece and Romania for pharmaceutical companies with an international presence, as well as developing the respective sales network.
Co-founder, CEO, and BoD Chairman of Stilvi Pharmaceuticals S.A. since 2013, active in Greece and abroad.
Despina Papadopoulou
20-year career in the pharmaceutical sector with experience both in Greek and multinational companies.
She has a successful background in a wide range of positions and accountabilities both in Sales, first as a Scientific Associate, and Marketing, at all levels, from Brand Manager and Group Brand Manager to Marketing Manager.
Characterised predominantly by creativity, a goal-oriented mindset and the ability to form, develop and manage highly efficient teams, she has been involved in launching and branding new products in the Greek and Cypriot markets, as well as in the development of research strategies for new business opportunities.
She has received international awards for the development of product promotion strategy, as well as for the development of awareness programmes for the general public.
Co-founder, CEO and BoD Deputy Chairwoman of STILVI Pharmaceuticals S.A. since 2013. From her position as Head of Operations, she contributes dynamically to the realisation of the company’s vision.
Stelios Fragkiskos
20-year career in Greek and multinational commercial and pharmaceutical corporations.
He has been working since 2004 in the pharmaceutical industry for Greek and multinational companies, initially in the Medical Information division and then in the Marketing division and has received significant distinctions in recognition for the outstanding achievement of his goals.
Being primarily characterised by a rigorous adherence to goals setting, ethos and meticulousness, he has contributed to the launch of new products and continuous increase in their sales, even after expiration of their patents.
He has been working for the promising company STILVI Pharmaceuticals S.A. since 2013, right from day one. He has been a company executive, initially as a Brand Manager, and then as a Marketing Manager. He currently holds the position of Marketing & Sales Manager and is also a member of the Board of Directors, helping the Company to develop its strategy towards realisation of its vision.
